NIA Impact Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
NIA Impact Advisors's GILD Position: Q1 2026 in Review
NIA Impact Advisors reduced its Gilead Sciences (GILD) stake by 8.7% in Q1 2026, selling an estimated $660K and leaving 49,642 shares worth $6.92M. The position accounts for 3.08% of the portfolio, ranked #6.
NIA Impact Advisors first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $7.01M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- NIA Impact Advisors held 49,642 shares of Gilead Sciences worth $6.92M as of Q1 2026.
- NIA Impact Advisors sold 4,712 Gilead Sciences shares in Q1 2026, an estimated $660K.
- Gilead Sciences made up 3.08% of NIA Impact Advisors's portfolio in Q1 2026, its #6 holding.
- NIA Impact Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
- NIA Impact Advisors's Gilead Sciences position peaked at $7.01M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on NIA Impact Advisors's 13F filing for Q1 2026, filed 8 May 2026.